Comparing the treatment outcomes between unresectable and recurrent cases receiving gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer: Pooled analysis of two prospective studies

被引：0
|
作者：
Sasaki, Takashi
Isayama, Hiroyuki
Ito, Yukiko
Yasuda, Ichiro
Toda, Nobuo
Yagioka, Hiroshi
Matsubara, Saburo
Hanada, Keiji
Maguchi, Hiroyuki
Kamada, Hideki
Hasebe, Osamu
Mukai, Tsuyoshi
Okabe, Sumihiro
Maetani, Iruru
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Japanese Red Cross Med Ctr, Tokyo, Japan
[3] Gifu Univ Hosp, Gifu, Japan
[4] Mitsui Mem Hosp, Tokyo, Japan
[5] JR Tokyo Gen Hosp, Tokyo, Japan
[6] Kanto Cent Hosp, Tokyo, Japan
[7] JA Onomichi Gen Hosp, Hiroshima, Japan
[8] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan
[9] Kagawa Univ Hosp, Kagawa, Japan
[10] Nagano Municipal Hosp, Nagano, Japan
[11] Gifu Municipal Hosp, Gifu, Japan
[12] Osaka Red Cross Hosp, Osaka, Japan
[13] Toho Univ, Ohashi Med Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.331
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
331
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A retrospective analysis comparing the treatment outcomes of gemcitabine and S-1 combination therapy to gemcitabine and cisplatin combination therapy in patients with advanced biliary tract cancer
    Sasaki, T.
    Isayama, H.
    Nakai, Y.
    Takahara, N.
    Yagioka, H.
    Ito, Y.
    Matsubara, S.
    Toda, N.
    Koike, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S624 - S625
  • [2] Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer: A Retrospective Study
    Mita, Kazuhito
    Ito, Hideto
    Fukumoto, Masato
    Murabayashi, Ryo
    Nabetani, Masashi
    Koizumi, Kazuya
    Hayashi, Takashi
    CASE REPORTS IN ONCOLOGY, 2010, 3 (03): : 498 - 504
  • [3] Phase Ⅰ trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Akinori Watanabe
    Mitsuhiro Kida
    Shiro Miyazawa
    Tomohisa Iwai
    Kosuke Okuwaki
    Toru Kaneko
    Hiroshi Yamauchi
    Miyoko Takezawa
    Hiroshi Imaizumi
    Wasaburo Koizumi
    World Journal of Gastroenterology, 2015, (19) : 5979 - 5984
  • [4] Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Yasuda, Ichiro
    Toda, Nobuo
    Yagioka, Hiroshi
    Matsubara, Saburo
    Hanada, Keiji
    Maguchi, Hiroyuki
    Kamada, Hideki
    Hasebe, Osamu
    Mukai, Tsuyoshi
    Okabe, Yoshihiro
    Maetani, Iruru
    Koike, Kazuhiko
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (48) : 18452 - 18457
  • [5] Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Ichiro Yasuda
    Nobuo Toda
    Hiroshi Yagioka
    Saburo Matsubara
    Keiji Hanada
    Hiroyuki Maguchi
    Hideki Kamada
    Osamu Hasebe
    Tsuyoshi Mukai
    Yoshihiro Okabe
    Iruru Maetani
    Kazuhiko Koike
    World Journal of Gastroenterology, 2014, (48) : 18452 - 18457
  • [6] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
  • [7] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Watanabe, Akinori
    Kida, Mitsuhiro
    Miyazawa, Shiro
    Iwai, Tomohisa
    Okuwaki, Kosuke
    Kaneko, Toru
    Yamauchi, Hiroshi
    Takezawa, Miyoko
    Imaizumi, Hiroshi
    Koizumi, Wasaburo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5979 - 5984
  • [8] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Toda, Nobuo
    Yasuda, Ichiro
    Hasebe, Osamu
    Maetani, Iruru
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1101 - 1107
  • [9] Clinical outcomes of gemcitabine, cisplatin plus S-1 in patients with advanced biliary tract cancer
    Niisato, Yusuke
    Ishida, Hiroyasu
    Onoda, Tsubasa
    Shimoyamada, Yudai
    Ito, Yuka
    Yamaguchi, Takashi
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Kim, Hyeong Su
    Kim, Ho Young
    Zang, Dae Young
    Oh, Ho Suk
    Jeon, Jang Yong
    Cho, Ji Woong
    Park, Choong Kee
    Kim, Jong Hyeok
    Kim, Min-Jeong
    Ha, Hong Il
    Kim, Jung Han
    Han, Boram
    Song, Hunho
    Kwon, Jung Hye
    Choi, Dae Ro
    Jung, Joo Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 711 - 718
12345